Current filters:  
USA
Healthcare
United States
Exponent
Updates on conducting a toxicological risk assessment of medical device extractable and leachable constituents for FDA submissions
Exponent
Four questions for developing inclusive digital solutions by identifying women-specific requirements and endpoints
Bass, Berry & Sims
The Bass, Berry & Sims Healthcare Private Equity Team is pleased to share with you our first installment of the BBS Connect Newsletter for 2024.
Ankura Consulting Group LLC
The Health Insurance Portability and Accountability Act (HIPAA) mandates stringent protections for the privacy and security of protected health information (PHI).
Farrell Fritz, P.C.
We live in an age of scientific miracles. We have an unprecedented ability to identify the causes of disease, and we have access to treatments, and even cures, we could not imagine only a few decades ago.
Ankura Consulting Group LLC
In 2023, U.S. pet industry spending reached $143.6 billion, reflecting over two decades of growth and resilience against economic downturns.
Sheppard Mullin Richter & Hampton
Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health-tech topics and trends of the day.
Dickinson Wright PLLC
One of the most popular incentives for service industry employees is the "Shift Drink" – a drink on the house to unwind after a work day.
Holland & Knight
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
Foley Hoag LLP
Nearly two years after the Court overturned Roe v. Wade in June 2022, additional challenges are being brought that may limit access to abortion in the U.S. Mifepristone...
Manatt, Phelps & Phillips LLP
In the aftermath of the Supreme Court's decision to overturn the federal constitutional right to abortion in Dobbs v. Jackson Women's Health Organization...
Crowell & Moring LLP
In the latest sign that federal enforcers remain focused on increasing antitrust enforcement, last Thursday, the Justice Department (DOJ), Federal Trade Commission ...
Exponent
Major revision to human factors engineering guidance for the design of medical devices slated for release later this year.
Manatt, Phelps & Phillips LLP
On March 18, the Biden Administration announced that it is doubling down on its commitment—previously announced during President Biden's State of the Union address...
Winston & Strawn LLP
The U.S. District Court for the Eastern District of Virginia is the latest court to weigh in on the continuing debate surrounding the scope of the Federal Anti-Kickback Statute (AKS) as it applies to patient assistance programs (PAPs).
Mintz
The PBM regulatory landscape continues to evolve rapidly at both federal and state levels, making it critical for our clients involved in the PBM space to stay apprised...
Holland & Knight
The Centers for Medicare & Medicaid Services (CMS) on April 10, 2024, released a proposed rule for the fiscal year (FY) 2025 Inpatient Prospective Payment System (IPPS)...
Duane Morris LLP
On April 5 2024 the U.S. Food and Drug Administration confirmed that its third-party testing of cosmetic tal products for 2023 identified no traces of asbestos in any of the 50 cosmetic samples tested.
Crowell & Moring LLP
Following federal lawmakers' initiative to lower prescription drug prices under the Inflation Reduction Act of 2022, several states have taken similar steps to limit certain drugs' prices.
Mintz
Of Counsel Benjamin Zegarelli and Associate Pat Ouellete discussed the health care regulations governing medical devices and software and shared how to stay informed and navigate the evolving landscape of health care regulations.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media